78 related articles for article (PubMed ID: 15243212)
1. Paraoxonase 1 activity, concentration and genotype in cardiovascular disease.
Mackness M; Durrington P; Mackness B
Curr Opin Lipidol; 2004 Aug; 15(4):399-404. PubMed ID: 15243212
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance.
Shunmoogam N; Naidoo P; Chilton R
Vasc Health Risk Manag; 2018; 14():137-143. PubMed ID: 29950852
[TBL] [Abstract][Full Text] [Related]
3. The genetics of vascular complications in diabetes mellitus.
Farbstein D; Levy AP
Cardiol Clin; 2010 Aug; 28(3):477-96. PubMed ID: 20621252
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Ex Vivo Antioxidative Potential of Murine HDL in Atherosclerosis.
Rivas-Urbina A; Rotllan N; Santos D; Julve J; Escolà-Gil JC; Sanchez-Quesada JL
Methods Mol Biol; 2022; 2419():283-292. PubMed ID: 35237971
[TBL] [Abstract][Full Text] [Related]
5. Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein.
Corsetti JP; Sparks CE; James RW; Bakker SJL; Dullaart RPF
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31480611
[TBL] [Abstract][Full Text] [Related]
6. Alterations of HDL Particles in Children with End-stage Renal Disease.
Stefanović A; Ristovski-Kornic D; Kotur-Stevuljević J; Spasojević-Kalimanovska V; Vekić J; Miljković M; Paripović D; Peco-Antic A; Jelić-Ivanović Z; Zeljković A
J Med Biochem; 2017 Oct; 36(4):358-365. PubMed ID: 30581333
[TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase 1 activity in patients with iron deficiency anemia.
Okuturlar Y; Gedikbasi A; Akalin N; Gunaldi M; Yilmaz D; Mert M; Harmankaya O; Soylu A; Karakaya P; Kumbasar A
Arch Med Sci; 2016 Aug; 12(4):697-703. PubMed ID: 27478448
[TBL] [Abstract][Full Text] [Related]
8. Profile of the Paraoxonase 1 (PON1) Gene 192Q/R Polymorphism and Clinical Associations among Older Singaporean Chinese with Alzheimer's and Mixed Dementia.
Seow DC; Gao Q; Yap P; Gan JM; Chionh HL; Lim SC; Feng L; Ng TP
Dement Geriatr Cogn Dis Extra; 2016; 6(1):43-54. PubMed ID: 27293416
[TBL] [Abstract][Full Text] [Related]
9. PON1 status evaluation in patients with chronic arterial occlusion of lower limbs due to atherosclerosis obliterans.
Kasprzak MP; Iskra M; Majewski W; Budzyń-Napierała M; Gryszczyńska B; Strzyżewski K; Kasprzak J
Arch Med Sci; 2014 Dec; 10(6):1101-8. PubMed ID: 25624845
[TBL] [Abstract][Full Text] [Related]
10. Emergent biomarkers of residual cardiovascular risk in patients with low HDL-c and/or high triglycerides and average LDL-c concentrations: focus on HDL subpopulations, Oxidized LDL, adiponectin, and uric acid.
Mascarenhas-Melo F; Palavra F; Marado D; Sereno J; Teixeira-Lemos E; Freitas I; Isabel-Mendonça M; Pinto R; Teixeira F; Reis F
ScientificWorldJournal; 2013; 2013():387849. PubMed ID: 24319364
[TBL] [Abstract][Full Text] [Related]
11. Implication of low HDL-c levels in patients with average LDL-c levels: a focus on oxidized LDL, large HDL subpopulation, and adiponectin.
Mascarenhas-Melo F; Sereno J; Teixeira-Lemos E; Marado D; Palavra F; Pinto R; Rocha-Pereira P; Teixeira F; Reis F
Mediators Inflamm; 2013; 2013():612038. PubMed ID: 24282340
[TBL] [Abstract][Full Text] [Related]
12. Serum paraoxonase activity and lipid hydroperoxide levels in adult football players after three days football tournament.
Atli M
Afr Health Sci; 2013 Sep; 13(3):565-70. PubMed ID: 24250290
[TBL] [Abstract][Full Text] [Related]
13. Serum paraoxonase and arylesterase activities and oxidative stress levels in patients with SSRI intoxication.
Katı C; Karadas S; Aslan M; Gonullu H; Duran L; Demir H
J Membr Biol; 2014 Jan; 247(1):17-21. PubMed ID: 24186356
[TBL] [Abstract][Full Text] [Related]
14. Markers of increased cardiovascular risk in postmenopausal women: focus on oxidized-LDL and HDL subpopulations.
Mascarenhas-Melo F; Sereno J; Teixeira-Lemos E; Ribeiro S; Rocha-Pereira P; Cotterill E; Teixeira F; Reis F
Dis Markers; 2013; 35(2):85-96. PubMed ID: 24167352
[TBL] [Abstract][Full Text] [Related]
15. The determination of Q192R polymorphism of paraoxonase 1 by using non-toxic substrate p-nitrophenylacetate.
Mogarekar MR; Chawhan SS
Indian J Hum Genet; 2013 Jan; 19(1):71-7. PubMed ID: 23901196
[TBL] [Abstract][Full Text] [Related]
16. Standardization of a method to evaluate the antioxidant capacity of high-density lipoproteins.
de Juan-Franco E; Pérez A; Ribas V; Sánchez-Hernández JA; Blanco-Vaca F; Ordóñez-Llanos J; Sánchez-Quesada JL
Int J Biomed Sci; 2009 Dec; 5(4):402-10. PubMed ID: 23675165
[TBL] [Abstract][Full Text] [Related]
17. The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects.
Akbas HS; Basyigit S; Suleymanlar I; Kemaloglu D; Koc S; Davran F; Demir I; Suleymanlar G
Lipids Health Dis; 2010 Aug; 9():92. PubMed ID: 20804546
[TBL] [Abstract][Full Text] [Related]
18. Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients.
Pereira SA; Batuca JR; Caixas U; Branco T; Delgado-Alves J; Germano I; Lampreia F; Monteiro EC
Br J Clin Pharmacol; 2009 Dec; 68(6):891-7. PubMed ID: 20002083
[TBL] [Abstract][Full Text] [Related]
19. In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes.
Gaidukov L; Bar D; Yacobson S; Naftali E; Kaufman O; Tabakman R; Tawfik DS; Levy-Nissenbaum E
BMC Clin Pharmacol; 2009 Nov; 9():18. PubMed ID: 19922610
[TBL] [Abstract][Full Text] [Related]
20. High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.
Kapur NK; Ashen D; Blumenthal RS
Vasc Health Risk Manag; 2008; 4(1):39-57. PubMed ID: 18629371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
